These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15241743)

  • 21. Sleep disorders in end-stage renal disease: 'Markers of inadequate dialysis'?
    Perl J; Unruh ML; Chan CT
    Kidney Int; 2006 Nov; 70(10):1687-93. PubMed ID: 16969388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease?
    Pinkau T; Hilgers KF; Veelken R; Mann JF
    J Am Soc Nephrol; 2004 Mar; 15(3):517-23. PubMed ID: 14978153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
    Fragoso A; Mendes F; Silva AP; Neves PL
    J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of vascular disease in renal failure.
    Ikizler TA
    Blood Purif; 2002; 20(1):6-10. PubMed ID: 11803153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome -- the heart of the matter.
    Pecoits-Filho R; Lindholm B; Stenvinkel P
    Nephrol Dial Transplant; 2002; 17 Suppl 11():28-31. PubMed ID: 12386254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of cardiovascular risk factors in chronic renal disease.
    Coresh J; Longenecker JC; Miller ER; Young HJ; Klag MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S24-30. PubMed ID: 11443765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular complications in end-stage renal disease and hemodialysis patients.
    Kes P; Drusko D; Rupcić V
    Acta Med Croatica; 1996; 50(4-5):199-208. PubMed ID: 9046118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penultimate pulse wave velocity, better than baseline pulse wave velocity, predicted mortality in Italian ESRD cohort study - a case for daily hemodialysis for ESRD patients with accelerated pulse wave velocity changes.
    Onuigbo M; Onuigbo N; Bellasi A; Russo D; Di Iorio BR
    G Ital Nefrol; 2013; 30(2):. PubMed ID: 23832464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arterial stiffness and pulse pressure in CKD and ESRD.
    Briet M; Boutouyrie P; Laurent S; London GM
    Kidney Int; 2012 Aug; 82(4):388-400. PubMed ID: 22534962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus.
    Lewis EF; Claggett B; Parfrey PS; Burdmann EA; McMurray JJ; Solomon SD; Levey AS; Ivanovich P; Eckardt KU; Kewalramani R; Toto R; Pfeffer MA
    Am Heart J; 2015 Aug; 170(2):322-9. PubMed ID: 26299230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal cardiovascular therapy for patients with ESRD over the next several years.
    Henrich WL
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S106-9. PubMed ID: 19995991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular issues in dialysis patients: challenges and newer insights.
    Guzon OJ; Dellsperger KC
    Adv Perit Dial; 2006; 22():111-5. PubMed ID: 16983952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis.
    Tang M; Batty JA; Lin C; Fan X; Chan KE; Kalim S
    Am J Kidney Dis; 2018 Jul; 72(1):75-83. PubMed ID: 29429751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular risk in stage 4 and 5 nephropathy.
    Yeo FE; Villines TC; Bucci JR; Taylor AJ; Abbott KC
    Adv Chronic Kidney Dis; 2004 Apr; 11(2):116-33. PubMed ID: 15216484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
    Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Undertreatment of cardiac risk factors in adolescents with renal failure.
    Querfeld U
    Perit Dial Int; 2001; 21 Suppl 3():S285-9. PubMed ID: 11887837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular problems on hemodialysis: current deficits and potential improvement.
    Ritz E; Bommer J
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S71-8. PubMed ID: 19996009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease.
    Rodriguez-Iturbe B; Correa-Rotter R
    Expert Opin Pharmacother; 2010 Nov; 11(16):2687-98. PubMed ID: 20426701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension.
    Sim JJ; Bhandari SK; Shi J; Reynolds K; Calhoun DA; Kalantar-Zadeh K; Jacobsen SJ
    Kidney Int; 2015 Sep; 88(3):622-32. PubMed ID: 25945406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arterial pressure components and cardiovascular risk in end-stage renal disease.
    Zoccali C
    Nephrol Dial Transplant; 2003 Feb; 18(2):249-52. PubMed ID: 12543876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.